Pfizer and BioNTech's COVID-19 vaccine is 100% effective against the virus in children ages 12 to 15, the companies announced in a press release Wednesday.. In a placebo-controlled trial of 2,260 ...

Pfizer’s announcement about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day, but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics.

Four years after former President Joe Biden’s Pentagon mandated the COVID-19 vaccination for all Department of Defense (DOD) ...

The vaccine needs to be stored at around -70 degrees Celsius. Early data revealed Monday that Pfizer's COVID-19 vaccine candidate could be up to 90% effective. The company still needs to submit ...

Drugmaker Pfizer says it's planning to start testing its COVID-19 vaccine on children as young as 12. Kids as young as 12 will be part of the trials, which was approved by the FDA this month.

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

Pfizer's COVID vaccine results, first reviewed by independent experts for effectiveness and safety, were shared by its team of scientists just five days after polls closed for the 2020 election on ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. 24/7 Live ...

COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. | COVID-19 tweets from November 2020 have ... about a successful phase 3 study of the company’s COVID vaccine.

Pfizer should have data on its three-dose vaccine trial for children ages 6 months to 5 years by April, Bourla told CBS on Sunday. If authorized by the FDA and recommended by the CDC, Covid-19 ...

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.